Answer:
Phase III
Explanation:
The given condition fall in the trial phase (Phase III) of cinical study which aims to:
- Determine drug's effectiveness (primary goal)
- Determine long-term drug safety
- Confirm findings
In Phase III, randomised, double-blind, placebo-controlled, parallel group study is majorly to evaluate the efficacy and safety of placebo in episodic migraine prevention in children (6 to < 12 years of age) and adolescents (12 to < 18 years of age).
The trial consists of four phases: screening; double-blind therapy period for 24 weeks in which placebo or Erenumab is given to subject as dose 1, dose 2 or dose 3 (based on the participant's body weight) once a month via subcutaneous injection; optional dose level blinded extension phase (40 weeks) which involves subjects recieve dose1, 2 and 3 of placebo, and at last it follows a safety follow-up phase for 12 weeks (after 16 weeks of the last dose of investigational drug).
Hence, the clinical phase is phase III.
Answer:
No, a person's genotype cannot be determined solely by their phenotype as many genes in our genome do not get expressed.
Explanation:
There are four phases to the cell cycle: G1, where the cell grows; S phase, where DNA is duplicated; G2, where the cell makes final preparations for cell division; and M phase, where the cell enters mitosis. Mitosis, or cell division, is only a small part of the cell cycle
How do the skeletal and muscular systems work together to maintain homeostasis? Blood cells are created in the bone marrow inside of the bones of the skeletal system. Blood vessels contained within carry nutrients to the bone. ... Muscles engage in shivering in order to increase body temperature when needed.
